JUL 27, 2015 01:31 PM PDT

Protein Imbalance Can Cause Cancer

While most scientists have viewed genetic aberrations as the primary cause of almost all cancer, a new study of ovarian cancer at the University of Leeds in the United Kingdom and the University of Texas MD Anderson Cancer Center suggests that cancer may be caused "solely by protein imbalances within cells." Published in the journal Oncogene and reported in Science Daily, the research shows how "protein imbalance is a powerful prognostic tool, indicating whether or not patients are likely to respond to chemotherapy and whether a tumor is likely to spread to other sites." This study could also lead to new therapies designed to measure and prevent dangerous protein imbalances in cells, the article explains (http://www.sciencedaily.com/releases/2015/07/150727092537.htm).
Cancer can have non-genetic causes.
According to the American Cancer Society, cancer, the second most common cause of death in the US, accounts for nearly one of every four deaths. The World Health Organization estimates that, worldwide, there were 4 million new cancer cases and 8.2 million cancer-related deaths in 2012 (http://www.medicalnewstoday.com/info/cancer-oncology/).

According to the lead author, Professor John Ladbury, Dean of the University of Leeds' Faculty of Biological Sciences and Professor of Mechanistic Biology, "There has been huge investment in sequencing the human genome with the idea that if we get all the relevant genetic information we can predict whether you have a predisposition to cancer and, ultimately, use a precision medicine-based approach to develop a therapeutic approach. Our study demonstrates that genetic screening alone is not enough."

The study concentrated on the "Akt pathway," a signaling pathway inside cells that drives cancer formation and the spread of cancers through the body. Normally, the cell would get external signals by means of a cell wall-bound receptor (FGFR2, in this research). Because of this stimulus, the receptor becomes "switched on" inside the cell, thus triggering the recruitment of signaling proteins and the initiation of the Akt pathway, which has the function of getting the cell to proliferate. According to the article, "In some cancerous cells, this pathway is permanently switched on. A conventional approach to diagnosing this cancer would be to look for genetic modification of the receptor (or recruited proteins), which could be responsible for maintaining the switched on state."

The researchers studied isolated cancer cells that did not have external stimulation and determined that the "Akt pathway" could be set in motion without genetic modifications. They found that two proteins -- Plc?1 and Grb2 -- compete for attaching to FGFR2. The relative concentration of these proteins determines which one does the binding. When Plc?1 succeeds, it stimulates the Akt pathway. Thus, an imbalance in the amount of the two proteins can trigger cell replication and cancer formation.

Now the researchers are studying the same mechanisms in other kinds of cancer. In addition, they are looking at other cell receptors that might play a role in sustaining oncogenic signaling without being activated.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JUN 06, 2018
Cell & Molecular Biology
JUN 06, 2018
New Role for Protein Complex Provides Insight Into Cancer Development
Researchers found that RSC plays an important role in chromosome distribution....
JUN 16, 2018
Cancer
JUN 16, 2018
Lung Cancer Rates Increasing in White and Hispanic Young Women
Lung cancer has long been tied to smoking and had a higher incidence in men than women. A new study shows rates of lung cancer are increasing in some groups of young women....
JUN 27, 2018
Cancer
JUN 27, 2018
Engineered Poliovirus in Clinical Trials for Glioblastoma
Glioblastoma is a very difficult cancer to treat; researchers look to an engineered poliovirus for novel targeted approach for grade IV patients....
JUL 12, 2018
Infographics
JUL 12, 2018
3D Imaging Advantage
Learn about the advantages and the technology behind 3D cellular image acquisition and analysis with this infographic from Molecular Devices....
OCT 06, 2018
Drug Discovery
OCT 06, 2018
New Class of Drugs for Breast Cancer Therapy
Scientists at Stevens Institute of Technology have designed a new class of molecules that may hold the potential to add to the arsenal of drugs actively be...
OCT 08, 2018
Immunology
OCT 08, 2018
Natural Killer Cells to Aid in Cancer Therapy
Researchers utilize nanoparticles to stimulate NK cells that induce tumor cells to express PDL1, a protein involved in immune response messaging...
Loading Comments...